Facile wet-chemical synthesis of graphene oxide/hydroxyapatite composite for potent, accelerated, and synergistic sonophotocatalytic degradation of diclofenac under light and ultrasound irradiation

The widespread disposal of pharmaceutical wastes, particularly diclofenac (DCF), poses a significant threat to aquatic ecosystems. The current degradation methods, including biological treatments and standalone advanced oxidation processes, often prove insufficient, leaving residual DCF concentrations. This study proposes a novel solution using a rapidly synthesized graphene oxide/hydroxyapatite (GO/HAp) nanocomposite via wet-chemical precipitation to enhance DCF degradation through synergistic sonophotocatalysis. The synthesized nanocomposite’s structure was confirmed using FTIR, XRD, and SEM analyses, revealing the successful formation of a hexagonal HAp phase on GO sheets. Optimization of the sonophotocatalytic parameters revealed that pH and loading significantly influenced degradation, while time had a less pronounced effect. The optimal conditions (a pH pf 4, 45 mg GO/HAp, 30 min) achieved a remarkable 93.86% DCF degradation, significantly outperforming standalone photocatalysis (72.76%) and sonolysis (63.76%). This enhanced performance is attributed to the synergistic effect of sonophotocatalysis, which increases the active surface area and radical generation, coupled with the high surface area and adsorption capacity of the GO/HAp nanocomposite. This research demonstrates that rapid wet-chemical synthesis of the GO/HAp nanocomposite, coupled with an optimized sonophotocatalytic process, offers a potent, accelerated, and efficient method for degrading DCF, paving the way for improved pharmaceutical wastewater treatment. Ultimately, this research provides a foundation for developing effective water treatment solutions to combat pharmaceutical contaminants.